Company Valuation: Amgen Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 126,718 140,139 154,142 140,103 176,250 229,736 - -
Change - 10.59% 9.99% -9.11% 25.8% 30.35% - -
Enterprise Value (EV) 1 151,990 169,779 207,811 188,229 221,725 271,093 265,040 260,168
Change - 11.7% 22.4% -9.42% 17.8% 22.27% -2.23% -1.84%
P/E 21.9x 21.7x 23.1x 34.5x 23x 27x 24.1x 23.1x
PBR 18.7x 38.3x 24.7x 23.8x 20.4x 20.5x 16.7x 13.4x
PEG - 1.2x 7.36x -0.9x 0.3x 2.5x 2x 5.37x
Capitalization / Revenue 4.88x 5.32x 5.47x 4.19x 4.8x 5.9x 5.69x 5.49x
EV / Revenue 5.85x 6.45x 7.37x 5.63x 6.03x 6.96x 6.57x 6.22x
EV / EBITDA 9.61x 10.5x 11.9x 9.13x 10.4x 12.5x 11.9x 11.7x
EV / EBIT 12.2x 13.3x 15.5x 12.5x 13.7x 16x 14.9x 14.1x
EV / FCF 18.1x 19.3x 28.2x 18.1x 27.4x 24.4x 17.8x 16.7x
FCF Yield 5.51% 5.17% 3.54% 5.52% 3.65% 4.1% 5.62% 6%
Dividend per Share 2 7.04 7.76 8.52 9 9.52 10.09 10.66 11.12
Rate of return 3.13% 2.95% 2.96% 3.45% 2.91% 2.37% 2.51% 2.62%
EPS 2 10.28 12.11 12.49 7.56 14.23 15.75 17.64 18.4
Distribution rate 68.5% 64.1% 68.2% 119% 66.9% 64.1% 60.4% 60.4%
Net sales 1 25,979 26,323 28,190 33,424 36,751 38,965 40,355 41,809
EBITDA 1 15,822 16,178 17,470 20,620 21,370 21,765 22,232 22,226
EBIT 1 12,424 12,761 13,399 15,028 16,203 16,946 17,758 18,505
Net income 1 5,893 6,552 6,717 4,090 7,711 8,540 9,426 9,983
Net Debt 1 25,272 29,640 53,669 48,126 45,475 41,357 35,304 30,432
Reference price 2 224.97 262.64 288.02 260.64 327.31 424.94 424.94 424.94
Nbr of stocks (in thousands) 563,266 533,579 535,178 537,533 538,481 540,632 - -
Announcement Date 07/02/22 31/01/23 06/02/24 04/02/25 03/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
35.75x12.79x26.94x0.55% 1,106B
37.14x6.26x17.62x2.1% 612B
36.08x8.31x17.14x2.43% 500B
20.6x4.98x12.38x2.63% 367B
104.7x5.86x25.15x2.37% 354B
21.05x5.51x13.55x2.9% 286B
21.56x4.37x12.5x2.02% 256B
26.98x6.96x12.46x2.37% 230B
-44.72x6.87x26.59x2.15% 190B
Average 28.79x 6.88x 18.26x 2.17% 433.35B
Weighted average by Cap. 34.40x 8.11x 19.89x 1.85%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Amgen Inc.

Historical PBR trend

Valuation ratios - PBR - Amgen Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Amgen Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Amgen Inc.


Year-on-year evolution of the Yield

Valuation ratios - Yield - Amgen Inc.